Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system

详细信息    查看全文

• 作者：Joshua Y. Menendez (1) jmenendez@uabmc.edu
  David F. Bauer (1)
  Chevis N. Shannon (1)
  John Fiveash (2)
  James M. Markert (1) jmarkert@uabmc.edu
• 关键词：Radiosurgery &#8211 ; Metastasis &#8211 ; Brain
• 刊名：Journal of Neuro-Oncology
• 出版年：2012
• 出版时间：September 2012
• 年：2012
• 卷：109
• 期：3
• 页码：513-519
• 全文大小：156.4 KB
• 参考文献：1. DiLuna MO, King JT, Knisley JP, Chiang VL (2007) Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases. Cancer 109:135–145
  2. Wen PY, Loeffler JS (2000) Brain metastases. Curr Treat Options Oncol 1:447–458
  3. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872
  4. Delattre JY, Krol G, Thaler HT, Posner JB (1988) Distribution of brain metastases. Arch Neurol 45:741–744
  5. Radbill AE, Fiveash JF, Falkenberg ET et al (2004) Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 101:825–833
  6. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514
  7. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL (2002) Stereotactic radiosurgery for patients with “radioresistant” brain metastases. Neurosurgery 51:656–665
  8. Flannery T, Kano H, Niranjan A et al (2010) Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases. Int J Radiat Oncol Biol Phys 76(2):513–519
  9. Tremont-Lukats IW, Bobustuc G, Lagos GK, Lolas K, Kyritsis AP, Puduvalli VK (2003) Brain metastasis from prostate carcinoma: The M. D Anderson Cancer Center Experience. Cancer 98:363–368
  10. Kim SH, Chao ST, Toms SA et al (2008) Stereotactic radiosurgery treatment of parenchymal brain metastases from prostate adenocarcinoma. Surg Neurol 69:641–646
  11. Flannery T, Kano H, Niranjan A, Monaco EA 3rd, Flickinger JC, Kofler J, Lunsford LD, Kondziolka D (2010) Stereotactic radiosurgery as a therapeutic strategy for intracranial metastatic prostate carcinoma. J Neurooncol 96:369–374
  12. Kim IY, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2009) Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer. J Neurooncol 93:355–359
  13. McWilliams RR, Cancer Giannin, Hay ID, Atkinson JL, Stafford SL, Buckner JC (2003) Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer 98:356–362
  14. Bernad DM, Sperduto PW, Souhami L, Jensen AW, Roberge D (2010) Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers. J Neurooncol 98(2):249–252. Epub 2010 Apr 8
  15. Shiohara S, Ohara M, Itoh K, Shiozawa T, Konish I (2003) Successful treatment with stereotactic radiosurgery for brain metastases of endometrial carcinoma: a case report and review of the literature. Int J Gynecol Cancer 13:71–76
  16. Monaco E, Kondizolka D, Mangia S, Niranjan A, Flickinger JC, Lunsford LD (2008) Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer 113:2610–2614
  17. Brown JV, Goldstein BH, Duma CM, Rettenmaier MA, Micha JP (2005) Gamma knife radiosurgery for treatment of ovarian cancer metastatic to the brain. Gynecol Oncol 97:858–861
  18. Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP (2008) Gamma knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol 108:505–509
  19. Mahmoud-Ahmed AS, Suh JH, Barnett GH, Webster KD, Kennedy AW (2001) Tumor distribution and survival in six patients with brain metastases from cervical carcinoma. Gynecol Oncol 81:196–200
  20. Weinberg JS, Suki D, Hanbali F, Cohen ZR, Lenzi R, Sawaya R (2003) Metastasis of esophageal carcinoma to the brain. Cancer 98:1925–1933
  21. Limbrick DD, Lusis EA, Chicoine MR et al (2009) Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases. Surg Neurol 71:280–289
  22. Hasegawa T, Kondziolka D, Flickinger JC, Lunsford LD (2003) Stereotactic radiosurgery for brain metastases from gastrointestinal tract cancer. Surg Neurol 60:506–514
  23. Da Silva AN, Nagayama K, Schlesinger DJ, Sheehan JP (2009) Gamma knife surgery for brain metastases from gastrointestinal cancer. J Neurosurg 111:423–430
  24. Mahmoud-Ahmed AS, Suh JH, Kupelian PA et al (2002) Brain metastases from bladder carcinoma: presentation, treatment and survival. J Urol 167:2419–2422
  25. Choi HJ, Cho BC, Sohn JH et al (2009) Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol 91:307–313
  26. Nicolato A, Ria A, Foroni R et al (2005) Gamma knife radiosurgery in brain metastases from testicular tumors. Med Oncol 22:45–56
• 作者单位：1. Division of Neurosurgery, Department of Surgery, University of Alabama at Birmingham, FOT 1060, 1530 3rd Avenue South, Birmingham, AL 35294, USA2. Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA
• ISSN：1573-7373

文摘

We evaluated the local control of gamma knife stereotactic radiosurgery (GKSRS) in the treatment of cerebral metastases from primary tumors that rarely metastasize to the central nervous system (CNS). There is little published data on this subject with very few series on specific primary tumors. We present our experience treating these lesions with GKSRS combined with a review of the salient literature. A retrospective study of 36 patients who collectively underwent 44 GKSRS procedures for CNS metastatic disease was undertaken. Our series includes four patients with sarcoma, two with prostate cancer, three with thyroid cancer, five with endometrial cancer, seven with ovarian cancer, two with cervical cancer, six with esophageal cancer, two with bladder cancer, one with liver cancer, one with pancreatic cancer, and three with testicular cancer. With 44 gamma knife sessions treating 74 tumors, 63 tumors showed no radiographic evidence of progression, and 13 tumors demonstrated radiographic progression between one and 12 months after gamma knife treatment. In six patients in the population, further treatment with GKSRS was necessary due to enlargement of untreated lesions or new metastatic disease. GKSRS for uncommon CNS metastases is appears to be efficacious in controlling the treated tumor. The majority of tumors treated in our study did not progress post gamma knife.